Jim Wallace has more than 30 years of experience litigating patents in the fields of communications satellites, data transmission, network interface devices, Internet business methods, pharmaceuticals, biotechnology, and semiconductors.

Representative Experience

• Secured, on behalf of client NTP Inc., a $612.5 million patent infringement settlement with Research In Motion Ltd. (RIM), the maker of BlackBerry wireless email devices. The settlement, one of the largest ever of its kind, resolved a fiercely contested, high-profile patent case stemming from a 2002 jury trial in which the firm successfully argued that RIM's core BlackBerry line of
wireless email products, software and services willfully infringed NTP patents.

• Litigated numerous pharmaceutical patent cases, including aripiprazole (Abilify®), cetuximab (Erbitux®), loratadine (Claritin®), oxybutynin chloride (Ditropan XL®), carbidopa/levodopa (Sinemet® CR), tamoxifen citrate (Nolvadex®), allopurinol (Zyloprim®), tPA (Activase®), omeprazole (Prilosec®), cyclobenzaprine HCI (Amrix®), erlotinib (Tarceva®), interferon (Roferon®-A), levofloxacin (Levaquin®), dutasteride (Avodart®), fenofibrate (Antara®), and tolterodine tartrate (Detrol® LA).

• Represented a developer of electronic imaging systems in a patent infringement action against 17 Japanese and Korean manufacturers involving the seeing-eye elements of camcorders and fax machines that convert light into electrons, known as charge coupled device (CCD) technology.

• Successfully represented clients in 337 patent infringement actions before the U.S. International Trade Commission (USITC), including a case involving novel microwave filters on satellites that, based upon their light weight, enabled increased satellite life.

• Successfully defended Royal Crown Cola in major antitrust challenge to exclusive geographic franchise agreements.

• On behalf of Royal Crown Cola successfully challenged, under the antitrust law, the proposed Pepsi/Seven Up and Coke/Dr. Pepper mergers.

• Secured a victory for client ARM Ltd. in defense of claims of patent infringement pertaining to the design of microprocessors.

• Filed an amicus brief, on behalf of Nobel Prize winner James D. Watson, in the landmark Myriad Genetics Inc. human gene patent case before the Supreme Court of the United States.